Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-11-01

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Machine Learning for Reclassification of Obesity

NCT04282837

Obesity

COMPLETED

Comparison of Gastric By-Pass and Optimized Medical Treatment in Obese Diabetic Patients

NCT01501201

Obesity Diabetes

RECRUITING PHASE4

European Study to Evaluate Preliminary Safety and Efficacy of Multiple Obalon Gastric Balloons for 12 Weeks as an Aid for Weight Loss

NCT01718886

Obesity Weight Control

COMPLETED

Safety Evaluation of the LGL102 in Obese Subjects Treated With OMS102

NCT01539850

Obesity Morbid Obesity

COMPLETED NA

Randomized Clinical Trial; Medical vs Bariatric Surgery for Adolescents (13-16 y) With Severe Obesity

NCT02378259

Obesity Diabetes Hypertension +2 more

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Despite evidence on the burden of BMI \>25, few disease-specific instruments comprehensively capture its multidimensional impact. Existing frameworks often target obesity (BMI ≥30) or patients on pharmacological or surgical therapy. Overweight and extremely obese populations are underrepresented, and economic and psychosocial dimensions are rarely integrated into severity staging.

This study, therefore, aims to systematically evaluate symptoms, comorbidities, HRQoL, and costs across the full spectrum of individuals with BMI \>25, excluding those on GLP-1 therapy. Integrating clinician and patient perspectives will support the development of more inclusive severity measures and inform early intervention strategies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Overweight (BMI > 25) Obesity & Overweight

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient group

1. Patient is aged ≥18 years at the time of survey completion.
2. Patient has a BMI over 25 (self-reported)
3. Patient is willing to participate in all study activities.
4. Patient is able to read, write, and converse in English.
* Healthcare professional participant must meet the following criteria for inclusion in the study:

1. HCP is aged ≥18 years at the time of survey completion.
2. HCP is suitably qualified and involved in the healthcare management of patients with a BMI over 25
3. HCP is willing to participate in all study activities.
4. HCP is able to read, write, and converse in English.

Exclusion Criteria

A participant who meets any of the following criteria will be excluded from the study:

1. Participants do not have the cognitive capacity to provide informed consent.
2. Participants with severe co-morbidity that might affect study participation.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes